Isolated distal deep vein thrombosis.
Conditions
Interventions
Control group:1) Anticoagulant treatment: barital (rivaroxaban tablet)
2) Comfort needle
Intervention group:1) Anticoagulant treatment: barital (rivaroxaban tablet)
2) Acupoint burying needle (press needle) take Hegu Neiguan and Zusanli points
Sponsors
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Both men and women aged 18 to 65 years; (2) Meet the diagnostic criteria for acute isolated distal deep vein thrombosis (first episode within 2 weeks symptoms of calf pain and swelling clear color ultrasound); (3) Subjects voluntarily join the study and sign a written informed consent.
Exclusion criteria
Exclusion criteria: (1) The patient has any anticoagulation contraindications; (2) The patient is pregnant and lactating; (3) Platelet count <100×10?/L; (4) Abnormal renal function; (5) Abnormal liver function associated with coagulopathy and higher blood risk; (6) There are contraindications to rivaroxaban use; (7) Clinically suspected or confirmed PE; (8) The presence of proximal deep vein thrombosis on the same or opposite side; (9) There are diseases requiring long-term anticoagulant therapy; (10) Patients with mental illness; (11) Life expectancy < 6 months; (12) Patients who had participated in other clinical trials within 3 months prior to screening; (13) Patients who were not considered suitable to participate in the study for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain symptoms improved 1 week after treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain symptoms improved at 2 weeks and 6 weeks after treatment;Recurrence rate of pain symptoms during the 6-week follow-up period; | — |
Countries
China
Contacts
Public ContactDandan-Yin
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed